this from march 2010, still another year guys
Unilife and sanofi-aventis Agree to Exclusivity List for UnifillTM Ready-to-Fill Syringe
Sanofi-aventis has secured exclusivity for the UnifillTM syringe (“Product”) within the full therapeutic classes of antithrombotic agents and vaccines until June 30, 2014 (“Period of Exclusivity”). These two therapeutic classes together represent the majority of all prefilled syringes consumed globally. Sanofi-aventis has also secured Product exclusivity in an additional six smaller sub-groups that fall within other therapeutic classes that Unilife believes represent new market opportunities in the pharmaceutical use of prefilled syringes.
for the full read
http://stocknessmonster.com/news-item?S=UNS&E=ASX&N=482502
Add to My Watchlist
What is My Watchlist?